PTBP3 and metabolic dysfunction-associated steatotic liver disease: Additionally, Ptbp3 can lead to alterations in lipid metabolism, contributing to lipid accumulation in liver cells, a hallmark of NAFLD and non-alcoholic steatohepatitis (NASH), creating a vicious cycle that promotes liver injury.